These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
431 related items for PubMed ID: 7538250
1. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1. Wrightham MN, Stewart JP, Janjua NJ, Pepper SD, Sample C, Rooney CM, Arrand JR. Virology; 1995 Apr 20; 208(2):521-30. PubMed ID: 7538250 [Abstract] [Full Text] [Related]
2. Precipitation of the Epstein-Barr virus protein EBNA 2 by an EBNA 3c-specific monoclonal antibody. Maunders MJ, Petti L, Rowe M. J Gen Virol; 1994 Apr 20; 75 ( Pt 4)():769-78. PubMed ID: 7512118 [Abstract] [Full Text] [Related]
3. Changes in the dominant Epstein-Barr virus type during human immunodeficiency virus infection. Buisson M, Morand P, Genoulaz O, Bourgeat MJ, Micoud M, Seigneurin JM. J Gen Virol; 1994 Feb 20; 75 ( Pt 2)():431-7. PubMed ID: 8113767 [Abstract] [Full Text] [Related]
4. The major immunogenic epitopes of Epstein-Barr virus (EBV) nuclear antigen 1 are encoded by sequence domains which vary among nasopharyngeal carcinoma biopsies and EBV-associated cell lines. Chen MR, Tsai CH, Wu FF, Kan SH, Yang CS, Chen JY. J Gen Virol; 1999 Feb 20; 80 ( Pt 2)():447-455. PubMed ID: 10073707 [Abstract] [Full Text] [Related]
5. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines. Finke J, Rowe M, Kallin B, Ernberg I, Rosén A, Dillner J, Klein G. J Virol; 1987 Dec 20; 61(12):3870-8. PubMed ID: 2824821 [Abstract] [Full Text] [Related]
6. The type-specific epitopes of the Epstein-Barr virus nuclear antigen 2 are near the carboxy terminus of the protein. Rowe DT, Clarke JR. J Gen Virol; 1989 May 20; 70 ( Pt 5)():1217-29. PubMed ID: 2471806 [Abstract] [Full Text] [Related]
7. The domain of Epstein-Barr virus nuclear antigen 1 essential for binding to oriP region has a sequence fitted for the hypothetical basic-helix-loop-helix structure. Inoue N, Harada S, Honma T, Kitamura T, Yanagi K. Virology; 1991 May 20; 182(1):84-93. PubMed ID: 1850915 [Abstract] [Full Text] [Related]
8. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised. Hill AB, Lee SP, Haurum JS, Murray N, Yao QY, Rowe M, Signoret N, Rickinson AB, McMichael AJ. J Exp Med; 1995 Jun 01; 181(6):2221-8. PubMed ID: 7539044 [Abstract] [Full Text] [Related]
9. EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif. Ling PD, Ryon JJ, Hayward SD. J Virol; 1993 Jun 01; 67(6):2990-3003. PubMed ID: 8388484 [Abstract] [Full Text] [Related]
10. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Levitskaya J, Coram M, Levitsky V, Imreh S, Steigerwald-Mullen PM, Klein G, Kurilla MG, Masucci MG. Nature; 1995 Jun 22; 375(6533):685-8. PubMed ID: 7540727 [Abstract] [Full Text] [Related]
11. The Epstein-Barr virus EBNA-2 gene in oral hairy leukoplakia: strain variation, genetic recombination, and transcriptional expression. Walling DM, Perkins AG, Webster-Cyriaque J, Resnick L, Raab-Traub N. J Virol; 1994 Dec 22; 68(12):7918-26. PubMed ID: 7966582 [Abstract] [Full Text] [Related]
13. Sequence analysis and variation of EBNA-1 in Epstein-Barr virus-related herpesvirus of cynomolgus monkey. Ohara N, Hayashi K, Teramoto N, Oka T, Fujimoto K, Yoshikawa Y, Castanos-Velez E, Biberfeld P, Akagi T. Intervirology; 2000 Jul 22; 43(2):102-6. PubMed ID: 10971128 [Abstract] [Full Text] [Related]
14. Synthetic peptides deduced from the amino acid sequence of Epstein-Barr virus nuclear antigen 6 (EBNA 6): antigenic properties, production of monoreactive reagents, and analysis of antibody responses in man. Falk K, Linde A, Johnson D, Lennette E, Ernberg I, Lundkvist A. J Med Virol; 1995 Aug 22; 46(4):349-57. PubMed ID: 7595412 [Abstract] [Full Text] [Related]
15. Epstein-Barr virus nuclear protein 2 is a critical determinant for tumor growth in SCID mice and for transformation in vitro. Cohen JI, Picchio GR, Mosier DE. J Virol; 1992 Dec 22; 66(12):7555-9. PubMed ID: 1331538 [Abstract] [Full Text] [Related]
17. HLA-A0201 and HLA-B7 binding peptides in the EBV-encoded EBNA-1, EBNA-2 and BZLF-1 proteins detected in the MHC class I stabilization assay. Low proportion of binding motifs for several HLA class I alleles in EBNA-1. Stuber G, Dillner J, Modrow S, Wolf H, Székely L, Klein G, Klein E. Int Immunol; 1995 Apr 22; 7(4):653-63. PubMed ID: 7547693 [Abstract] [Full Text] [Related]
18. The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4. Levitsky V, Zhang QJ, Levitskaya J, Masucci MG. J Exp Med; 1996 Mar 01; 183(3):915-26. PubMed ID: 8642295 [Abstract] [Full Text] [Related]
19. DNA-binding studies of the Epstein-Barr virus nuclear antigen 2 (EBNA-2): evidence for complex formation by latent membrane protein gene promoter-binding proteins in EBNA-2-positive cell lines. Sauder C, Haiss P, Grässer FA, Zimber-Strobl U, Mueller-Lantzsch N. J Gen Virol; 1994 Nov 01; 75 ( Pt 11)():3067-79. PubMed ID: 7964616 [Abstract] [Full Text] [Related]
20. Transcriptional regulatory properties of Epstein-Barr virus nuclear antigen 3C are conserved in simian lymphocryptoviruses. Zhao B, Dalbiès-Tran R, Jiang H, Ruf IK, Sample JT, Wang F, Sample CE. J Virol; 2003 May 01; 77(10):5639-48. PubMed ID: 12719556 [Abstract] [Full Text] [Related] Page: [Next] [New Search]